Literature DB >> 11919561

Molecular characterization of inter-telomere and intra-telomere mutations in human ALT cells.

Helen Varley1, Hilda A Pickett, Jennifer L Foxon, Roger R Reddel, Nicola J Royle.   

Abstract

Telomeres in most immortal cells are maintained by the enzyme telomerase, allowing cells to divide indefinitely. Some telomerase-negative tumors and immortal cell lines maintain long heterogeneous telomeres by the ALT (alternative lengthening of telomeres) mechanism; such tumors are expected to be resistant to anti-telomerase drug therapies. Occasionally telomerase-negative Saccharomyces cerevisiae mutants survive, and 10% of them (type II survivors) have unstable telomeres. As in human ALT+ cells, short telomeres in yeast type II survivors lengthen abruptly; in yeast, this is dependent on the recombination proteins Rad52p and Rad50p. In human cells, ALT involves copying of sequence from a donor to a recipient telomere. We have characterized for the first time a class of complex telomere mutations seen only in ALT+ cells. The mutant telomeres are defined by the replacement of the progenitor telomere at a discrete point (fusion point) with a different telomere repeat array. Among 19 characterized fusion points, one occurred within the first six repeats of the telomere, indicating that these recombination-like events can occur anywhere within the telomere. One mutant telomere may have been involved in a secondary recombination-like mutation event, suggesting that these mutations are sporadic but ongoing in ALT+ cells. We also identified simple intra-allelic mutations at high frequency, which evidently contribute to telomere instability in ALT+ cells.

Entities:  

Mesh:

Year:  2002        PMID: 11919561     DOI: 10.1038/ng834

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  43 in total

1.  Translocation breakpoint mapping and sequence analysis in three monosomy 1p36 subjects with der(1)t(1;1)(p36;q44) suggest mechanisms for telomere capture in stabilizing de novo terminal rearrangements.

Authors:  Blake C Ballif; Keiko Wakui; Marzena Gajecka; Lisa G Shaffer
Journal:  Hum Genet       Date:  2003-10-25       Impact factor: 4.132

2.  Genomic instability in both wild-type and telomerase null MEFs.

Authors:  Ling-Yang Hao; Carol W Greider
Journal:  Chromosoma       Date:  2004-07-16       Impact factor: 4.316

3.  Homologous recombination in human telomerase-positive and ALT cells occurs with the same frequency.

Authors:  Oliver E Bechter; Ying Zou; Jerry W Shay; Woodring E Wright
Journal:  EMBO Rep       Date:  2003-11-14       Impact factor: 8.807

Review 4.  Molecular mechanisms of activity and derepression of alternative lengthening of telomeres.

Authors:  Hilda A Pickett; Roger R Reddel
Journal:  Nat Struct Mol Biol       Date:  2015-11-04       Impact factor: 15.369

5.  Telomerase- and recombination-independent immortalization of budding yeast.

Authors:  Laura Maringele; David Lydall
Journal:  Genes Dev       Date:  2004-10-15       Impact factor: 11.361

6.  An increase in telomere sister chromatid exchange in murine embryonic stem cells possessing critically shortened telomeres.

Authors:  Yisong Wang; Natalie Erdmann; Richard J Giannone; Jun Wu; Marla Gomez; Yie Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-06       Impact factor: 11.205

7.  Of wombats and whales: telomere tales in Madrid. Conference on telomeres and telomerase.

Authors:  Jan Karlseder; Julia Promisel Cooper
Journal:  EMBO Rep       Date:  2007-05-18       Impact factor: 8.807

8.  Inter-telomeric recombination is present in telomerase-positive human cells.

Authors:  Margit Dlaska; Patrick Schöffski; Oliver E Bechter
Journal:  Cell Cycle       Date:  2013-06-06       Impact factor: 4.534

9.  Fanconi anemia proteins and endogenous stresses.

Authors:  Qishen Pang; Paul R Andreassen
Journal:  Mutat Res       Date:  2009-07-31       Impact factor: 2.433

10.  A role for monoubiquitinated FANCD2 at telomeres in ALT cells.

Authors:  Qiang Fan; Fan Zhang; Briana Barrett; Keqin Ren; Paul R Andreassen
Journal:  Nucleic Acids Res       Date:  2009-01-07       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.